5 Best Robotics Stocks Under $10

Page 5 of 5

1. Stereotaxis, Inc. (NASDAQ:STXS)

Number of Hedge Fund Holders: 23

Share Price (as of May 20): $1.80

Stereotaxis, Inc. (NASDAQ:STXS) manufactures robotic magnetic navigation (RMN) systems which enable minimally invasive endovascular surgeries. The firm’s technology provides surgeons with image-guided delivery of catheters and guidewires into blood vessels and chambers of the heart.

Loop Capital analyst Jason Wittes in January initiated coverage of Stereotaxis, Inc. (NASDAQ:STXS) with a ‘Buy’ rating and a $13 price target. The analyst noted that the firm has developed an advanced robotic platform for endovascular surgery that makes use of magnets as opposed to less effective mechanical arms or automated guidewires to move catheters through clogged vessels. He believes the company’s new catheter system launching later this year will “dramatically” enhance its growth and profitability profile. Craig-Hallum analyst Alex Nowak also gave Stereotaxis, Inc. (NASDAQ:STXS) a ‘Buy’ rating in January, along with a price target of $11.

23 hedge funds held positions in Stereotaxis, Inc. (NASDAQ:STXS) at the conclusion of the fourth quarter, as compared to 26 hedge funds a quarter before. The total value of Q4 hedge funds holdings was recorded at $179.8 million. In the first quarter, DAFNA Capital Management held a $51 million stake in Stereotaxis, Inc. (NASDAQ:STXS) which represented 13.29% of its total portfolio, and made it the firm’s largest shareholder.

The company posted $7.04 million in revenue for the first quarter, which exceeded estimates by $368,000. EPS was recorded in-line with estimates at -$0.06.

You can also take a look at 15 Largest Food Delivery Companies in the World and Bill Gates’ Stock Portfolio: Top 15 Picks

Page 5 of 5